PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Magalie,Dosset ^[1] ; Thaiz Rivera,Vargas ^[2] ; Anaïs,Lagrange ^[3] ; Romain,Boidot ^[4] ; Frédérique,Végran ^[1] ; Aurélie,Roussey ^[4] ; Fanny,Chalmin ^[1] ; Lucile,Dondaine ^[4] ; Catherine,Paul ^[1] ; Elodie,Lauret Marie-Joseph ^[4] ; François,Martin ^[5] ; Bernhard,Ryffel ^[1] ; Christophe,Borg ^[4] ; Olivier,Adotévi ^[5] ; François,Ghiringhelli ^[1] ; Lionel,Apetoh ^[4]

作者单位： INSERM, U1231, Dijon, France. ^[1] INSERM, U1098, Besançon, France. ^[2] LabEx LipSTIC, Besançon, France. ^[3] Université de Bourgogne Franche Comté, Dijon, France. ^[4] Centre Georges François Leclerc, Dijon, France. ^[5] University of Cape Town, RSA, CNRS, UMR7355, Orleans, France, IDM. ^[6] Department of Medical Oncology, University Hospital of Besançon, France. ^[7]

关键词 CD8?T cells PD-1/PD-L1 pathway chemotherapy colorectal cancer, adaptive immune resistance immunotherapy

DOI 10.1080/2162402X.2018.1433981

PMID 29872568

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览14

Oncoimmunology

e1433981页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.

Oncoimmunology

相似文献

Oncoimmunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.

Oncoimmunology

相似文献

Oncoimmunology

相关期刊

检索历史清除